SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma

This publication has 27 references indexed in Scilit:

• SALL4 as a new biomarker for early colorectal cancers
  Journal of Cancer Research and Clinical Oncology, 2014
• Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma
  Human Pathology, 2014
• Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma
  Medical Oncology, 2014
• Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma
  World Journal of Gastrointestinal Pathophysiology, 2014
• SALL4, a novel marker for human gastric carcinogenesis and metastasis
  Oncogene, 2013
• Sal-like protein 4: an epithelial and germ cell marker
  Human Pathology, 2013
• Overexpression of SALL4 in lung cancer and its importance in cell proliferation
  Oncology Reports, 2011
• Diagnostic Utility of SALL4 in Extragonadal Yolk Sac Tumors
  American Journal of Surgical Pathology, 2009
• Murine inner cell mass-derived lineages depend on Sall4 function
  Proceedings of the National Academy of Sciences, 2006
• Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1
  Nature Cell Biology, 2006